By using the genomic PCR assay, we did not find a significant change of TBL1XR1 copy number in NPC tissues (Additional file 2: Figure S2), indicating that TBL1XR1 overexpression is not due to the genomic amplification. This evidence concerns the gene TBL1XR1 and nasopharyngeal carcinoma.